Laser & Skin Surgery Center of Indiana Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2013
NCT01820260
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Laser & Skin Surgery Center of Indiana,

Active Ingredients

Drugs in Phase 3 Trials (1)

ingenol mebutate (picato) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Keratosis (Phase 3)

Keratosis, Actinic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1